<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T11:56:05Z</responseDate>
  <request identifier="oai:figshare.com:article/32592124" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/32592124</identifier>
        <datestamp>2026-09-17T19:05:14Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_13</setSpec>
        <setSpec>category_15</setSpec>
        <setSpec>category_16</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>portal_63</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Development and Biological Characterization of Fluorescent
Dynorphins for the Visualization of Kappa Opioid Receptors</dc:title>
          <dc:creator>Predrag Kalaba (4169968)</dc:creator>
          <dc:creator>Monika Perisic Böhm (24141907)</dc:creator>
          <dc:creator>Filip D̵ikić (24141910)</dc:creator>
          <dc:creator>Nataša Tomašević (11019445)</dc:creator>
          <dc:creator>Ruth Drdla-Schutting (24141913)</dc:creator>
          <dc:creator>Simon Hasinger (22043092)</dc:creator>
          <dc:creator>Dylan M. Ines (14342048)</dc:creator>
          <dc:creator>Alexandra Wolf (222309)</dc:creator>
          <dc:creator>Mireia Belil-Catalina (24141916)</dc:creator>
          <dc:creator>Sharon D. Bryant (2488435)</dc:creator>
          <dc:creator>Mariana Spetea (576206)</dc:creator>
          <dc:creator>Christian W. Gruber (176571)</dc:creator>
          <dc:creator>Markus Muttenthaler (176572)</dc:creator>
          <dc:creator>Erik Keimpema (17255121)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Genetics</dc:subject>
          <dc:subject>Neuroscience</dc:subject>
          <dc:subject>Physiology</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>superficial layer neurons</dc:subject>
          <dc:subject>spinal cord neurons</dc:subject>
          <dc:subject>post hoc &lt;/</dc:subject>
          <dc:subject>kappa opioid receptors</dc:subject>
          <dc:subject>kappa opioid receptor</dc:subject>
          <dc:subject>effectively visualize kors</dc:subject>
          <dc:subject>closely related mu</dc:subject>
          <dc:subject>highly valuable tool</dc:subject>
          <dc:subject>mapping kor expression</dc:subject>
          <dc:subject>kor agonist u50</dc:subject>
          <dc:subject>kor (&gt; 360</dc:subject>
          <dc:subject>wide variety</dc:subject>
          <dc:subject>somatodendritic compartment</dc:subject>
          <dc:subject>reward responses</dc:subject>
          <dc:subject>pathophysiological contexts</dc:subject>
          <dc:subject>lead tracer</dc:subject>
          <dc:subject>induced reduction</dc:subject>
          <dc:subject>including pain</dc:subject>
          <dc:subject>highly selective</dc:subject>
          <dc:subject>fluorescent dynorphins</dc:subject>
          <dc:subject>family members</dc:subject>
          <dc:subject>excitatory drive</dc:subject>
          <dc:subject>developing dynorphin</dc:subject>
          <dc:subject>developed tracer</dc:subject>
          <dc:subject>biological processes</dc:subject>
          <dc:subject>biological characterization</dc:subject>
          <dc:description>The kappa opioid receptor (KOR) controls a wide variety of biological
processes, including pain and reward responses. However, its precise
spatiotemporal location remains poorly understood due to limited selective
molecular tools. We addressed this problem by developing dynorphin-based
fluorescent KOR tracers that are selective for KOR over its closely
related mu- and delta-family members (MOR, DOR). Our lead tracer is
highly selective for KOR (&gt;360-fold over MOR and DOR) and can effectively
visualize KORs in the somatodendritic compartment of cultured primary
cortical neurons, as well as in superficial layer neurons of the spinal
cord dorsal horn. Furthermore, it blocked the KOR agonist U50,488-induced
reduction in the excitatory drive of spinal cord neurons. The developed
tracer can also be immobilized with paraformaldehyde and used for &lt;i&gt;post hoc&lt;/i&gt; imaging, rendering it a highly valuable tool for
mapping KOR expression in physiological and pathophysiological contexts.</dc:description>
          <dc:date>2026-06-25T00:00:00Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1021/acs.jmedchem.5c03072.s002</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Development_and_Biological_Characterization_of_Fluorescent_Dynorphins_for_the_Visualization_of_Kappa_Opioid_Receptors/32592124</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
